sn int64 | NP string | bacteria string | strain string | NP_synthesis string | drug string | drug_dose_µg_disk float64 | NP_concentration_µg_ml float64 | NP_size_min_nm string | NP_size_max_nm float64 | NP_size_avg_nm float64 | shape string | method string | ZOI_drug_mm_or_MIC _µg_ml float64 | error_ZOI_drug_mm_or_MIC_µg_ml float64 | ZOI_NP_mm_or_MIC_np_µg_ml float64 | error_ZOI_NP_mm_or_MIC_np_µg_ml float64 | ZOI_drug_NP_mm_or_MIC_drug_NP_µg_ml float64 | error_ZOI_drug_NP_mm_or_MIC_drug_NP_µg_ml float64 | fold_increase_in_antibacterial_activity float64 | zeta_potential_mV string | MDR string | FIC float64 | effect string | reference string | doi string | article_list int64 | time_hr float64 | coating_with_antimicrobial_peptide_polymers string | combined_MIC float64 | peptide_MIC float64 | viability_% float64 | viability_error float64 | journal_name string | publisher string | year int64 | title string | journal_is_oa bool | is_oa bool | oa_status string | pdf string | access int64 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
101 | Ag | Salmonella typhimurium | NCIM 2501 | green_synthesis using Acinetobacter calcoaceticus | Amoxicillin | null | null | 8 | 12 | 10 | spherical | MBC | null | null | null | null | null | null | null | null | null | null | null | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3826770/ | 10.3390/antibiotics11091205 | 3 | 20 | null | null | null | null | null | Antibiotics | MDPI AG | 2,022 | Silver Nanoparticle-Based Therapy: Can It Be Useful to Combat Multi-Drug Resistant Bacteria? | true | true | gold | 3_antibiotics-11-01205-v2.pdf | 1 |
102 | Ag | Salmonella typhimurium | NCIM 2501 | green_synthesis using Acinetobacter calcoaceticus | Ampicillin | null | null | 8 | 12 | 10 | spherical | MBC | 32 | null | null | null | 0.015 | null | null | null | null | null | null | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3826770/ | 10.3390/antibiotics11091205 | 3 | 20 | null | null | null | null | null | Antibiotics | MDPI AG | 2,022 | Silver Nanoparticle-Based Therapy: Can It Be Useful to Combat Multi-Drug Resistant Bacteria? | true | true | gold | 3_antibiotics-11-01205-v2.pdf | 1 |
103 | Ag | Salmonella typhimurium | NCIM 2501 | green_synthesis using Acinetobacter calcoaceticus | Penicillin | null | null | 8 | 12 | 10 | spherical | MBC | null | null | null | null | null | null | null | null | null | null | null | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3826770/ | 10.3390/antibiotics11091205 | 3 | 20 | null | null | null | null | null | Antibiotics | MDPI AG | 2,022 | Silver Nanoparticle-Based Therapy: Can It Be Useful to Combat Multi-Drug Resistant Bacteria? | true | true | gold | 3_antibiotics-11-01205-v2.pdf | 1 |
104 | Ag | Salmonella typhimurium | NCIM 2501 | green_synthesis using Acinetobacter calcoaceticus | Ceftazidime | null | null | 8 | 12 | 10 | spherical | MBC | 2 | null | null | null | 0.015 | null | null | null | null | null | null | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3826770/ | 10.3390/antibiotics11091205 | 3 | 20 | null | null | null | null | null | Antibiotics | MDPI AG | 2,022 | Silver Nanoparticle-Based Therapy: Can It Be Useful to Combat Multi-Drug Resistant Bacteria? | true | true | gold | 3_antibiotics-11-01205-v2.pdf | 1 |
105 | Ag | Salmonella typhimurium | NCIM 2501 | green_synthesis using Acinetobacter calcoaceticus | Ceftriaxone | null | null | 8 | 12 | 10 | spherical | MBC | 16 | null | null | null | 0.015 | null | null | null | null | null | null | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3826770/ | 10.3390/antibiotics11091205 | 3 | 20 | null | null | null | null | null | Antibiotics | MDPI AG | 2,022 | Silver Nanoparticle-Based Therapy: Can It Be Useful to Combat Multi-Drug Resistant Bacteria? | true | true | gold | 3_antibiotics-11-01205-v2.pdf | 1 |
106 | Ag | Salmonella typhimurium | NCIM 2501 | green_synthesis using Acinetobacter calcoaceticus | Vancomycin | null | null | 8 | 12 | 10 | spherical | MBC | null | null | null | null | null | null | null | null | null | null | null | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3826770/ | 10.3390/antibiotics11091205 | 3 | 20 | null | null | null | null | null | Antibiotics | MDPI AG | 2,022 | Silver Nanoparticle-Based Therapy: Can It Be Useful to Combat Multi-Drug Resistant Bacteria? | true | true | gold | 3_antibiotics-11-01205-v2.pdf | 1 |
107 | Ag | Salmonella typhimurium | NCIM 2501 | green_synthesis using Acinetobacter calcoaceticus | Ciprofloxacin | null | null | 8 | 12 | 10 | spherical | MBC | 0.25 | null | null | null | 0.25 | null | null | null | null | null | null | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3826770/ | 10.3390/antibiotics11091205 | 3 | 20 | null | null | null | null | null | Antibiotics | MDPI AG | 2,022 | Silver Nanoparticle-Based Therapy: Can It Be Useful to Combat Multi-Drug Resistant Bacteria? | true | true | gold | 3_antibiotics-11-01205-v2.pdf | 1 |
108 | Ag | Salmonella typhimurium | NCIM 2501 | green_synthesis using Acinetobacter calcoaceticus | Doxycycline | null | null | 8 | 12 | 10 | spherical | MBC | 64 | null | null | null | 0.015 | null | null | null | null | null | null | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3826770/ | 10.3390/antibiotics11091205 | 3 | 20 | null | null | null | null | null | Antibiotics | MDPI AG | 2,022 | Silver Nanoparticle-Based Therapy: Can It Be Useful to Combat Multi-Drug Resistant Bacteria? | true | true | gold | 3_antibiotics-11-01205-v2.pdf | 1 |
109 | Ag | Salmonella typhimurium | NCIM 2501 | green_synthesis using Acinetobacter calcoaceticus | Tetracycline | null | null | 8 | 12 | 10 | spherical | MBC | 128 | null | null | null | 0.5 | null | null | null | null | null | null | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3826770/ | 10.3390/antibiotics11091205 | 3 | 20 | null | null | null | null | null | Antibiotics | MDPI AG | 2,022 | Silver Nanoparticle-Based Therapy: Can It Be Useful to Combat Multi-Drug Resistant Bacteria? | true | true | gold | 3_antibiotics-11-01205-v2.pdf | 1 |
110 | Ag | Salmonella typhimurium | NCIM 2501 | green_synthesis using Acinetobacter calcoaceticus | Chloramphenicol | null | null | 8 | 12 | 10 | spherical | MBC | 128 | null | null | null | 0.015 | null | null | null | null | null | null | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3826770/ | 10.3390/antibiotics11091205 | 3 | 20 | null | null | null | null | null | Antibiotics | MDPI AG | 2,022 | Silver Nanoparticle-Based Therapy: Can It Be Useful to Combat Multi-Drug Resistant Bacteria? | true | true | gold | 3_antibiotics-11-01205-v2.pdf | 1 |
111 | Ag | Salmonella typhimurium | NCIM 2501 | green_synthesis using Acinetobacter calcoaceticus | Trimethoprim | null | null | 8 | 12 | 10 | spherical | MBC | 16 | null | null | null | 0.015 | null | null | null | null | null | null | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3826770/ | 10.3390/antibiotics11091205 | 3 | 20 | null | null | null | null | null | Antibiotics | MDPI AG | 2,022 | Silver Nanoparticle-Based Therapy: Can It Be Useful to Combat Multi-Drug Resistant Bacteria? | true | true | gold | 3_antibiotics-11-01205-v2.pdf | 1 |
112 | Ag | Staphylococcus aureus | MTCC 3160 | green_synthesis using Acinetobacter calcoaceticus | Amikacin | null | null | 8 | 12 | 10 | spherical | MBC | 1 | null | null | null | 0.015 | null | null | null | null | null | null | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3826770/ | 10.3390/antibiotics11091205 | 3 | 20 | null | null | null | null | null | Antibiotics | MDPI AG | 2,022 | Silver Nanoparticle-Based Therapy: Can It Be Useful to Combat Multi-Drug Resistant Bacteria? | true | true | gold | 3_antibiotics-11-01205-v2.pdf | 1 |
113 | Ag | Staphylococcus aureus | MTCC 3160 | green_synthesis using Acinetobacter calcoaceticus | Gentamicin | null | null | 8 | 12 | 10 | spherical | MBC | 0.125 | null | null | null | 0.125 | null | null | null | null | null | null | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3826770/ | 10.3390/antibiotics11091205 | 3 | 20 | null | null | null | null | null | Antibiotics | MDPI AG | 2,022 | Silver Nanoparticle-Based Therapy: Can It Be Useful to Combat Multi-Drug Resistant Bacteria? | true | true | gold | 3_antibiotics-11-01205-v2.pdf | 1 |
114 | Ag | Staphylococcus aureus | MTCC 3160 | green_synthesis using Acinetobacter calcoaceticus | Kanamycin | null | null | 8 | 12 | 10 | spherical | MBC | 1 | null | null | null | 0.125 | null | null | null | null | null | null | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3826770/ | 10.3390/antibiotics11091205 | 3 | 20 | null | null | null | null | null | Antibiotics | MDPI AG | 2,022 | Silver Nanoparticle-Based Therapy: Can It Be Useful to Combat Multi-Drug Resistant Bacteria? | true | true | gold | 3_antibiotics-11-01205-v2.pdf | 1 |
115 | Ag | Staphylococcus aureus | MTCC 3160 | green_synthesis using Acinetobacter calcoaceticus | Amoxicillin | null | null | 8 | 12 | 10 | spherical | MBC | 2,048 | null | null | null | 128 | null | null | null | null | null | null | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3826770/ | 10.3390/antibiotics11091205 | 3 | 20 | null | null | null | null | null | Antibiotics | MDPI AG | 2,022 | Silver Nanoparticle-Based Therapy: Can It Be Useful to Combat Multi-Drug Resistant Bacteria? | true | true | gold | 3_antibiotics-11-01205-v2.pdf | 1 |
116 | Ag | Staphylococcus aureus | MTCC 3160 | green_synthesis using Acinetobacter calcoaceticus | Ampicillin | null | null | 8 | 12 | 10 | spherical | MBC | 512 | null | null | null | 64 | null | null | null | null | null | null | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3826770/ | 10.3390/antibiotics11091205 | 3 | 20 | null | null | null | null | null | Antibiotics | MDPI AG | 2,022 | Silver Nanoparticle-Based Therapy: Can It Be Useful to Combat Multi-Drug Resistant Bacteria? | true | true | gold | 3_antibiotics-11-01205-v2.pdf | 1 |
117 | Ag | Staphylococcus aureus | MTCC 3160 | green_synthesis using Acinetobacter calcoaceticus | Penicillin | null | null | 8 | 12 | 10 | spherical | MBC | 4,096 | null | null | null | 0.125 | null | null | null | null | null | null | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3826770/ | 10.3390/antibiotics11091205 | 3 | 20 | null | null | null | null | null | Antibiotics | MDPI AG | 2,022 | Silver Nanoparticle-Based Therapy: Can It Be Useful to Combat Multi-Drug Resistant Bacteria? | true | true | gold | 3_antibiotics-11-01205-v2.pdf | 1 |
118 | Ag | Staphylococcus aureus | MTCC 3160 | green_synthesis using Acinetobacter calcoaceticus | Ceftazidime | null | null | 8 | 12 | 10 | spherical | MBC | 0.5 | null | null | null | 0.06 | null | null | null | null | null | null | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3826770/ | 10.3390/antibiotics11091205 | 3 | 20 | null | null | null | null | null | Antibiotics | MDPI AG | 2,022 | Silver Nanoparticle-Based Therapy: Can It Be Useful to Combat Multi-Drug Resistant Bacteria? | true | true | gold | 3_antibiotics-11-01205-v2.pdf | 1 |
119 | Ag | Staphylococcus aureus | MTCC 3160 | green_synthesis using Acinetobacter calcoaceticus | Ceftriaxone | null | null | 8 | 12 | 10 | spherical | MBC | 1 | null | null | null | 0.25 | null | null | null | null | null | null | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3826770/ | 10.3390/antibiotics11091205 | 3 | 20 | null | null | null | null | null | Antibiotics | MDPI AG | 2,022 | Silver Nanoparticle-Based Therapy: Can It Be Useful to Combat Multi-Drug Resistant Bacteria? | true | true | gold | 3_antibiotics-11-01205-v2.pdf | 1 |
120 | Ag | Staphylococcus aureus | MTCC 3160 | green_synthesis using Acinetobacter calcoaceticus | Vancomycin | null | null | 8 | 12 | 10 | spherical | MBC | 512 | null | null | null | 64 | null | null | null | null | null | null | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3826770/ | 10.3390/antibiotics11091205 | 3 | 20 | null | null | null | null | null | Antibiotics | MDPI AG | 2,022 | Silver Nanoparticle-Based Therapy: Can It Be Useful to Combat Multi-Drug Resistant Bacteria? | true | true | gold | 3_antibiotics-11-01205-v2.pdf | 1 |
121 | Ag | Staphylococcus aureus | MTCC 3160 | green_synthesis using Acinetobacter calcoaceticus | Ciprofloxacin | null | null | 8 | 12 | 10 | spherical | MBC | 0.015 | null | null | null | 0.015 | null | null | null | null | null | null | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3826770/ | 10.3390/antibiotics11091205 | 3 | 20 | null | null | null | null | null | Antibiotics | MDPI AG | 2,022 | Silver Nanoparticle-Based Therapy: Can It Be Useful to Combat Multi-Drug Resistant Bacteria? | true | true | gold | 3_antibiotics-11-01205-v2.pdf | 1 |
122 | Ag | Staphylococcus aureus | MTCC 3160 | green_synthesis using Acinetobacter calcoaceticus | Doxycycline | null | null | 8 | 12 | 10 | spherical | MBC | 32 | null | null | null | 4 | null | null | null | null | null | null | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3826770/ | 10.3390/antibiotics11091205 | 3 | 20 | null | null | null | null | null | Antibiotics | MDPI AG | 2,022 | Silver Nanoparticle-Based Therapy: Can It Be Useful to Combat Multi-Drug Resistant Bacteria? | true | true | gold | 3_antibiotics-11-01205-v2.pdf | 1 |
123 | Ag | Staphylococcus aureus | MTCC 3160 | green_synthesis using Acinetobacter calcoaceticus | Tetracycline | null | null | 8 | 12 | 10 | spherical | MBC | 16 | null | null | null | 2 | null | null | null | null | null | null | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3826770/ | 10.3390/antibiotics11091205 | 3 | 20 | null | null | null | null | null | Antibiotics | MDPI AG | 2,022 | Silver Nanoparticle-Based Therapy: Can It Be Useful to Combat Multi-Drug Resistant Bacteria? | true | true | gold | 3_antibiotics-11-01205-v2.pdf | 1 |
124 | Ag | Staphylococcus aureus | MTCC 3160 | green_synthesis using Acinetobacter calcoaceticus | Chloramphenicol | null | null | 8 | 12 | 10 | spherical | MBC | 4,096 | null | null | null | 1,024 | null | null | null | null | null | null | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3826770/ | 10.3390/antibiotics11091205 | 3 | 20 | null | null | null | null | null | Antibiotics | MDPI AG | 2,022 | Silver Nanoparticle-Based Therapy: Can It Be Useful to Combat Multi-Drug Resistant Bacteria? | true | true | gold | 3_antibiotics-11-01205-v2.pdf | 1 |
125 | Ag | Staphylococcus aureus | MTCC 3160 | green_synthesis using Acinetobacter calcoaceticus | Trimethoprim | null | null | 8 | 12 | 10 | spherical | MBC | 2 | null | null | null | 0.5 | null | null | null | null | null | null | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3826770/ | 10.3390/antibiotics11091205 | 3 | 20 | null | null | null | null | null | Antibiotics | MDPI AG | 2,022 | Silver Nanoparticle-Based Therapy: Can It Be Useful to Combat Multi-Drug Resistant Bacteria? | true | true | gold | 3_antibiotics-11-01205-v2.pdf | 1 |
126 | Ag | Streptococcus mutans | MTCC 497 | green_synthesis using Acinetobacter calcoaceticus | Amikacin | null | null | 8 | 12 | 10 | spherical | MBC | null | null | null | null | null | null | null | null | null | null | null | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3826770/ | 10.3390/antibiotics11091205 | 3 | 20 | null | null | null | null | null | Antibiotics | MDPI AG | 2,022 | Silver Nanoparticle-Based Therapy: Can It Be Useful to Combat Multi-Drug Resistant Bacteria? | true | true | gold | 3_antibiotics-11-01205-v2.pdf | 1 |
127 | Ag | Streptococcus mutans | MTCC 497 | green_synthesis using Acinetobacter calcoaceticus | Gentamicin | null | null | 8 | 12 | 10 | spherical | MBC | null | null | null | null | null | null | null | null | null | null | null | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3826770/ | 10.3390/antibiotics11091205 | 3 | 20 | null | null | null | null | null | Antibiotics | MDPI AG | 2,022 | Silver Nanoparticle-Based Therapy: Can It Be Useful to Combat Multi-Drug Resistant Bacteria? | true | true | gold | 3_antibiotics-11-01205-v2.pdf | 1 |
128 | Ag | Streptococcus mutans | MTCC 497 | green_synthesis using Acinetobacter calcoaceticus | Kanamycin | null | null | 8 | 12 | 10 | spherical | MBC | null | null | null | null | null | null | null | null | null | null | null | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3826770/ | 10.3390/antibiotics11091205 | 3 | 20 | null | null | null | null | null | Antibiotics | MDPI AG | 2,022 | Silver Nanoparticle-Based Therapy: Can It Be Useful to Combat Multi-Drug Resistant Bacteria? | true | true | gold | 3_antibiotics-11-01205-v2.pdf | 1 |
129 | Ag | Streptococcus mutans | MTCC 497 | green_synthesis using Acinetobacter calcoaceticus | Amoxicillin | null | null | 8 | 12 | 10 | spherical | MBC | null | null | null | null | null | null | null | null | null | null | null | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3826770/ | 10.3390/antibiotics11091205 | 3 | 20 | null | null | null | null | null | Antibiotics | MDPI AG | 2,022 | Silver Nanoparticle-Based Therapy: Can It Be Useful to Combat Multi-Drug Resistant Bacteria? | true | true | gold | 3_antibiotics-11-01205-v2.pdf | 1 |
130 | Ag | Streptococcus mutans | MTCC 497 | green_synthesis using Acinetobacter calcoaceticus | Ampicillin | null | null | 8 | 12 | 10 | spherical | MBC | 64 | null | null | null | 32 | null | null | null | null | null | null | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3826770/ | 10.3390/antibiotics11091205 | 3 | 20 | null | null | null | null | null | Antibiotics | MDPI AG | 2,022 | Silver Nanoparticle-Based Therapy: Can It Be Useful to Combat Multi-Drug Resistant Bacteria? | true | true | gold | 3_antibiotics-11-01205-v2.pdf | 1 |
131 | Ag | Streptococcus mutans | MTCC 497 | green_synthesis using Acinetobacter calcoaceticus | Penicillin | null | null | 8 | 12 | 10 | spherical | MBC | 128 | null | null | null | 2 | null | null | null | null | null | null | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3826770/ | 10.3390/antibiotics11091205 | 3 | 20 | null | null | null | null | null | Antibiotics | MDPI AG | 2,022 | Silver Nanoparticle-Based Therapy: Can It Be Useful to Combat Multi-Drug Resistant Bacteria? | true | true | gold | 3_antibiotics-11-01205-v2.pdf | 1 |
132 | Ag | Streptococcus mutans | MTCC 497 | green_synthesis using Acinetobacter calcoaceticus | Ceftazidime | null | null | 8 | 12 | 10 | spherical | MBC | 16 | null | null | null | 0.015 | null | null | null | null | null | null | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3826770/ | 10.3390/antibiotics11091205 | 3 | 20 | null | null | null | null | null | Antibiotics | MDPI AG | 2,022 | Silver Nanoparticle-Based Therapy: Can It Be Useful to Combat Multi-Drug Resistant Bacteria? | true | true | gold | 3_antibiotics-11-01205-v2.pdf | 1 |
133 | Ag | Streptococcus mutans | MTCC 497 | green_synthesis using Acinetobacter calcoaceticus | Ceftriaxone | null | null | 8 | 12 | 10 | spherical | MBC | 2 | null | null | null | 0.015 | null | null | null | null | null | null | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3826770/ | 10.3390/antibiotics11091205 | 3 | 20 | null | null | null | null | null | Antibiotics | MDPI AG | 2,022 | Silver Nanoparticle-Based Therapy: Can It Be Useful to Combat Multi-Drug Resistant Bacteria? | true | true | gold | 3_antibiotics-11-01205-v2.pdf | 1 |
134 | Ag | Streptococcus mutans | MTCC 497 | green_synthesis using Acinetobacter calcoaceticus | Vancomycin | null | null | 8 | 12 | 10 | spherical | MBC | 4 | null | null | null | 0.125 | null | null | null | null | null | null | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3826770/ | 10.3390/antibiotics11091205 | 3 | 20 | null | null | null | null | null | Antibiotics | MDPI AG | 2,022 | Silver Nanoparticle-Based Therapy: Can It Be Useful to Combat Multi-Drug Resistant Bacteria? | true | true | gold | 3_antibiotics-11-01205-v2.pdf | 1 |
135 | Ag | Streptococcus mutans | MTCC 497 | green_synthesis using Acinetobacter calcoaceticus | Ciprofloxacin | null | null | 8 | 12 | 10 | spherical | MBC | null | null | null | null | null | null | null | null | null | null | null | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3826770/ | 10.3390/antibiotics11091205 | 3 | 20 | null | null | null | null | null | Antibiotics | MDPI AG | 2,022 | Silver Nanoparticle-Based Therapy: Can It Be Useful to Combat Multi-Drug Resistant Bacteria? | true | true | gold | 3_antibiotics-11-01205-v2.pdf | 1 |
136 | Ag | Streptococcus mutans | MTCC 497 | green_synthesis using Acinetobacter calcoaceticus | Doxycycline | null | null | 8 | 12 | 10 | spherical | MBC | null | null | null | null | null | null | null | null | null | null | null | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3826770/ | 10.3390/antibiotics11091205 | 3 | 20 | null | null | null | null | null | Antibiotics | MDPI AG | 2,022 | Silver Nanoparticle-Based Therapy: Can It Be Useful to Combat Multi-Drug Resistant Bacteria? | true | true | gold | 3_antibiotics-11-01205-v2.pdf | 1 |
137 | Ag | Streptococcus mutans | MTCC 497 | green_synthesis using Acinetobacter calcoaceticus | Tetracycline | null | null | 8 | 12 | 10 | spherical | MBC | 1 | null | null | null | 0.015 | null | null | null | null | null | null | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3826770/ | 10.3390/antibiotics11091205 | 3 | 20 | null | null | null | null | null | Antibiotics | MDPI AG | 2,022 | Silver Nanoparticle-Based Therapy: Can It Be Useful to Combat Multi-Drug Resistant Bacteria? | true | true | gold | 3_antibiotics-11-01205-v2.pdf | 1 |
138 | Ag | Streptococcus mutans | MTCC 497 | green_synthesis using Acinetobacter calcoaceticus | Chloramphenicol | null | null | 8 | 12 | 10 | spherical | MBC | 4 | null | null | null | 0.5 | null | null | null | null | null | null | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3826770/ | 10.3390/antibiotics11091205 | 3 | 20 | null | null | null | null | null | Antibiotics | MDPI AG | 2,022 | Silver Nanoparticle-Based Therapy: Can It Be Useful to Combat Multi-Drug Resistant Bacteria? | true | true | gold | 3_antibiotics-11-01205-v2.pdf | 1 |
139 | Ag | Streptococcus mutans | MTCC 497 | green_synthesis using Acinetobacter calcoaceticus | Trimethoprim | null | null | 8 | 12 | 10 | spherical | MBC | 4 | null | null | null | 0.015 | null | null | null | null | null | null | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3826770/ | 10.3390/antibiotics11091205 | 3 | 20 | null | null | null | null | null | Antibiotics | MDPI AG | 2,022 | Silver Nanoparticle-Based Therapy: Can It Be Useful to Combat Multi-Drug Resistant Bacteria? | true | true | gold | 3_antibiotics-11-01205-v2.pdf | 1 |
140 | Ag | Escherichia coli | 25922 | purchased from US Research Nanomaterials, Inc. | Ampicillin | null | null | 15 | 25 | 20 | spherical | MIC | 2 | null | 64 | null | 32 | null | null | 1.9 | null | null | null | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9495250/ | 10.3390/antibiotics11091219 | 4 | 18 | null | null | null | null | null | Antibiotics | MDPI AG | 2,022 | Silver Nanoparticle-Based Combinations with Antimicrobial Agents against Antimicrobial-Resistant Clinical Isolates | true | true | gold | 4_antibiotics-11-01219-v2.pdf | 1 |
141 | Ag | Klebsiella pneumoniae | 13883 | purchased from US Research Nanomaterials, Inc. | Ampicillin | null | null | 15 | 25 | 20 | spherical | MIC | 256 | null | 128 | null | null | null | null | 1.9 | null | null | null | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9495250/ | 10.3390/antibiotics11091219 | 4 | 18 | null | null | null | null | null | Antibiotics | MDPI AG | 2,022 | Silver Nanoparticle-Based Combinations with Antimicrobial Agents against Antimicrobial-Resistant Clinical Isolates | true | true | gold | 4_antibiotics-11-01219-v2.pdf | 1 |
142 | Ag | Pseudomonas aeruginosa | 27853 | purchased from US Research Nanomaterials, Inc. | Ampicillin | null | null | 15 | 25 | 20 | spherical | MIC | 256 | null | 16 | null | null | null | null | 1.9 | null | null | null | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9495250/ | 10.3390/antibiotics11091219 | 4 | 18 | null | null | null | null | null | Antibiotics | MDPI AG | 2,022 | Silver Nanoparticle-Based Combinations with Antimicrobial Agents against Antimicrobial-Resistant Clinical Isolates | true | true | gold | 4_antibiotics-11-01219-v2.pdf | 1 |
143 | Ag | Acinetobacter baumannii | BAA-747 | purchased from US Research Nanomaterials, Inc. | Ampicillin | null | null | 15 | 25 | 20 | spherical | MIC | 16 | null | 32 | null | null | null | null | 1.9 | null | null | null | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9495250/ | 10.3390/antibiotics11091219 | 4 | 18 | null | null | null | null | null | Antibiotics | MDPI AG | 2,022 | Silver Nanoparticle-Based Combinations with Antimicrobial Agents against Antimicrobial-Resistant Clinical Isolates | true | true | gold | 4_antibiotics-11-01219-v2.pdf | 1 |
144 | Ag | Staphylococcus aureus | 29213 | purchased from US Research Nanomaterials, Inc. | Ampicillin | null | null | 15 | 25 | 20 | spherical | MIC | 256 | null | 256 | null | null | null | null | 1.9 | null | null | null | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9495250/ | 10.3390/antibiotics11091219 | 4 | 18 | null | null | null | null | null | Antibiotics | MDPI AG | 2,022 | Silver Nanoparticle-Based Combinations with Antimicrobial Agents against Antimicrobial-Resistant Clinical Isolates | true | true | gold | 4_antibiotics-11-01219-v2.pdf | 1 |
145 | Ag | Staphylococcus saprophyticus | 49453 | purchased from US Research Nanomaterials, Inc. | Ampicillin | null | null | 15 | 25 | 20 | spherical | MIC | 256 | null | 256 | null | null | null | null | 1.9 | null | null | null | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9495250/ | 10.3390/antibiotics11091219 | 4 | 18 | null | null | null | null | null | Antibiotics | MDPI AG | 2,022 | Silver Nanoparticle-Based Combinations with Antimicrobial Agents against Antimicrobial-Resistant Clinical Isolates | true | true | gold | 4_antibiotics-11-01219-v2.pdf | 1 |
146 | Ag | Staphylococcus sciuri | 29061 | purchased from US Research Nanomaterials, Inc. | Ampicillin | null | null | 15 | 25 | 20 | spherical | MIC | 256 | null | 256 | null | null | null | null | 1.9 | null | null | null | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9495250/ | 10.3390/antibiotics11091219 | 4 | 18 | null | null | null | null | null | Antibiotics | MDPI AG | 2,022 | Silver Nanoparticle-Based Combinations with Antimicrobial Agents against Antimicrobial-Resistant Clinical Isolates | true | true | gold | 4_antibiotics-11-01219-v2.pdf | 1 |
147 | Ag | Staphylococcus epidermidis | 12228 | purchased from US Research Nanomaterials, Inc. | Ampicillin | null | null | 15 | 25 | 20 | spherical | MIC | 256 | null | 256 | null | null | null | null | 1.9 | null | null | null | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9495250/ | 10.3390/antibiotics11091219 | 4 | 18 | null | null | null | null | null | Antibiotics | MDPI AG | 2,022 | Silver Nanoparticle-Based Combinations with Antimicrobial Agents against Antimicrobial-Resistant Clinical Isolates | true | true | gold | 4_antibiotics-11-01219-v2.pdf | 1 |
148 | Ag | Escherichia coli | 25922 | purchased from US Research Nanomaterials, Inc. | Kanamycin | null | null | 15 | 25 | 20 | spherical | MIC | 2 | null | 64 | null | 4 | null | null | 1.9 | null | null | null | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9495250/ | 10.3390/antibiotics11091219 | 4 | 18 | null | null | null | null | null | Antibiotics | MDPI AG | 2,022 | Silver Nanoparticle-Based Combinations with Antimicrobial Agents against Antimicrobial-Resistant Clinical Isolates | true | true | gold | 4_antibiotics-11-01219-v2.pdf | 1 |
149 | Ag | Klebsiella pneumoniae | 13883 | purchased from US Research Nanomaterials, Inc. | Kanamycin | null | null | 15 | 25 | 20 | spherical | MIC | 1 | null | 128 | null | null | null | null | 1.9 | null | null | null | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9495250/ | 10.3390/antibiotics11091219 | 4 | 18 | null | null | null | null | null | Antibiotics | MDPI AG | 2,022 | Silver Nanoparticle-Based Combinations with Antimicrobial Agents against Antimicrobial-Resistant Clinical Isolates | true | true | gold | 4_antibiotics-11-01219-v2.pdf | 1 |
150 | Ag | Pseudomonas aeruginosa | 27853 | purchased from US Research Nanomaterials, Inc. | Kanamycin | null | null | 15 | 25 | 20 | spherical | MIC | 256 | null | 16 | null | null | null | null | 1.9 | null | null | null | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9495250/ | 10.3390/antibiotics11091219 | 4 | 18 | null | null | null | null | null | Antibiotics | MDPI AG | 2,022 | Silver Nanoparticle-Based Combinations with Antimicrobial Agents against Antimicrobial-Resistant Clinical Isolates | true | true | gold | 4_antibiotics-11-01219-v2.pdf | 1 |
151 | Ag | Acinetobacter baumannii | BAA-747 | purchased from US Research Nanomaterials, Inc. | Kanamycin | null | null | 15 | 25 | 20 | spherical | MIC | 4 | null | 32 | null | null | null | null | 1.9 | null | null | null | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9495250/ | 10.3390/antibiotics11091219 | 4 | 18 | null | null | null | null | null | Antibiotics | MDPI AG | 2,022 | Silver Nanoparticle-Based Combinations with Antimicrobial Agents against Antimicrobial-Resistant Clinical Isolates | true | true | gold | 4_antibiotics-11-01219-v2.pdf | 1 |
152 | Ag | Staphylococcus aureus | 29213 | purchased from US Research Nanomaterials, Inc. | Kanamycin | null | null | 15 | 25 | 20 | spherical | MIC | 4 | null | 256 | null | null | null | null | 1.9 | null | null | null | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9495250/ | 10.3390/antibiotics11091219 | 4 | 18 | null | null | null | null | null | Antibiotics | MDPI AG | 2,022 | Silver Nanoparticle-Based Combinations with Antimicrobial Agents against Antimicrobial-Resistant Clinical Isolates | true | true | gold | 4_antibiotics-11-01219-v2.pdf | 1 |
153 | Ag | Staphylococcus saprophyticus | 49453 | purchased from US Research Nanomaterials, Inc. | Kanamycin | null | null | 15 | 25 | 20 | spherical | MIC | 0.5 | null | 256 | null | null | null | null | 1.9 | null | null | null | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9495250/ | 10.3390/antibiotics11091219 | 4 | 18 | null | null | null | null | null | Antibiotics | MDPI AG | 2,022 | Silver Nanoparticle-Based Combinations with Antimicrobial Agents against Antimicrobial-Resistant Clinical Isolates | true | true | gold | 4_antibiotics-11-01219-v2.pdf | 1 |
154 | Ag | Staphylococcus sciuri | 29061 | purchased from US Research Nanomaterials, Inc. | Kanamycin | null | null | 15 | 25 | 20 | spherical | MIC | 8 | null | 256 | null | null | null | null | 1.9 | null | null | null | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9495250/ | 10.3390/antibiotics11091219 | 4 | 18 | null | null | null | null | null | Antibiotics | MDPI AG | 2,022 | Silver Nanoparticle-Based Combinations with Antimicrobial Agents against Antimicrobial-Resistant Clinical Isolates | true | true | gold | 4_antibiotics-11-01219-v2.pdf | 1 |
155 | Ag | Staphylococcus epidermidis | 12228 | purchased from US Research Nanomaterials, Inc. | Kanamycin | null | null | 15 | 25 | 20 | spherical | MIC | null | null | 256 | null | null | null | null | 1.9 | null | null | null | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9495250/ | 10.3390/antibiotics11091219 | 4 | 18 | null | null | null | null | null | Antibiotics | MDPI AG | 2,022 | Silver Nanoparticle-Based Combinations with Antimicrobial Agents against Antimicrobial-Resistant Clinical Isolates | true | true | gold | 4_antibiotics-11-01219-v2.pdf | 1 |
156 | Ag | Escherichia coli | 25922 | purchased from US Research Nanomaterials, Inc. | Vancomycin | null | null | 15 | 25 | 20 | spherical | MIC | 256 | null | 64 | null | 4 | null | null | 1.9 | null | null | null | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9495250/ | 10.3390/antibiotics11091219 | 4 | 18 | null | null | null | null | null | Antibiotics | MDPI AG | 2,022 | Silver Nanoparticle-Based Combinations with Antimicrobial Agents against Antimicrobial-Resistant Clinical Isolates | true | true | gold | 4_antibiotics-11-01219-v2.pdf | 1 |
157 | Ag | Klebsiella pneumoniae | 13883 | purchased from US Research Nanomaterials, Inc. | Vancomycin | null | null | 15 | 25 | 20 | spherical | MIC | 256 | null | 128 | null | null | null | null | 1.9 | null | null | null | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9495250/ | 10.3390/antibiotics11091219 | 4 | 18 | null | null | null | null | null | Antibiotics | MDPI AG | 2,022 | Silver Nanoparticle-Based Combinations with Antimicrobial Agents against Antimicrobial-Resistant Clinical Isolates | true | true | gold | 4_antibiotics-11-01219-v2.pdf | 1 |
158 | Ag | Pseudomonas aeruginosa | 27853 | purchased from US Research Nanomaterials, Inc. | Vancomycin | null | null | 15 | 25 | 20 | spherical | MIC | 256 | null | 16 | null | null | null | null | 1.9 | null | null | null | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9495250/ | 10.3390/antibiotics11091219 | 4 | 18 | null | null | null | null | null | Antibiotics | MDPI AG | 2,022 | Silver Nanoparticle-Based Combinations with Antimicrobial Agents against Antimicrobial-Resistant Clinical Isolates | true | true | gold | 4_antibiotics-11-01219-v2.pdf | 1 |
159 | Ag | Acinetobacter baumannii | BAA-747 | purchased from US Research Nanomaterials, Inc. | Vancomycin | null | null | 15 | 25 | 20 | spherical | MIC | 256 | null | 32 | null | null | null | null | 1.9 | null | null | null | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9495250/ | 10.3390/antibiotics11091219 | 4 | 18 | null | null | null | null | null | Antibiotics | MDPI AG | 2,022 | Silver Nanoparticle-Based Combinations with Antimicrobial Agents against Antimicrobial-Resistant Clinical Isolates | true | true | gold | 4_antibiotics-11-01219-v2.pdf | 1 |
160 | Ag | Staphylococcus aureus | 29213 | purchased from US Research Nanomaterials, Inc. | Vancomycin | null | null | 15 | 25 | 20 | spherical | MIC | 1 | null | 256 | null | null | null | null | 1.9 | null | null | null | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9495250/ | 10.3390/antibiotics11091219 | 4 | 18 | null | null | null | null | null | Antibiotics | MDPI AG | 2,022 | Silver Nanoparticle-Based Combinations with Antimicrobial Agents against Antimicrobial-Resistant Clinical Isolates | true | true | gold | 4_antibiotics-11-01219-v2.pdf | 1 |
161 | Ag | Staphylococcus saprophyticus | 49453 | purchased from US Research Nanomaterials, Inc. | Vancomycin | null | null | 15 | 25 | 20 | spherical | MIC | 1 | null | 256 | null | null | null | null | 1.9 | null | null | null | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9495250/ | 10.3390/antibiotics11091219 | 4 | 18 | null | null | null | null | null | Antibiotics | MDPI AG | 2,022 | Silver Nanoparticle-Based Combinations with Antimicrobial Agents against Antimicrobial-Resistant Clinical Isolates | true | true | gold | 4_antibiotics-11-01219-v2.pdf | 1 |
162 | Ag | Staphylococcus sciuri | 29061 | purchased from US Research Nanomaterials, Inc. | Vancomycin | null | null | 15 | 25 | 20 | spherical | MIC | 0.5 | null | 256 | null | null | null | null | 1.9 | null | null | null | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9495250/ | 10.3390/antibiotics11091219 | 4 | 18 | null | null | null | null | null | Antibiotics | MDPI AG | 2,022 | Silver Nanoparticle-Based Combinations with Antimicrobial Agents against Antimicrobial-Resistant Clinical Isolates | true | true | gold | 4_antibiotics-11-01219-v2.pdf | 1 |
163 | Ag | Staphylococcus epidermidis | 12228 | purchased from US Research Nanomaterials, Inc. | Vancomycin | null | null | 15 | 25 | 20 | spherical | MIC | 2 | null | 256 | null | null | null | null | 1.9 | null | null | null | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9495250/ | 10.3390/antibiotics11091219 | 4 | 18 | null | null | null | null | null | Antibiotics | MDPI AG | 2,022 | Silver Nanoparticle-Based Combinations with Antimicrobial Agents against Antimicrobial-Resistant Clinical Isolates | true | true | gold | 4_antibiotics-11-01219-v2.pdf | 1 |
164 | Ag | Escherichia coli | 25922 | purchased from US Research Nanomaterials, Inc. | Ciprofloxacin | null | null | 15 | 25 | 20 | spherical | MIC | 0.015 | null | 64 | null | 32 | null | null | 1.9 | null | null | null | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9495250/ | 10.3390/antibiotics11091219 | 4 | 18 | null | null | null | null | null | Antibiotics | MDPI AG | 2,022 | Silver Nanoparticle-Based Combinations with Antimicrobial Agents against Antimicrobial-Resistant Clinical Isolates | true | true | gold | 4_antibiotics-11-01219-v2.pdf | 1 |
165 | Ag | Klebsiella pneumoniae | 13883 | purchased from US Research Nanomaterials, Inc. | Ciprofloxacin | null | null | 15 | 25 | 20 | spherical | MIC | 0.25 | null | 128 | null | null | null | null | 1.9 | null | null | null | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9495250/ | 10.3390/antibiotics11091219 | 4 | 18 | null | null | null | null | null | Antibiotics | MDPI AG | 2,022 | Silver Nanoparticle-Based Combinations with Antimicrobial Agents against Antimicrobial-Resistant Clinical Isolates | true | true | gold | 4_antibiotics-11-01219-v2.pdf | 1 |
166 | Ag | Pseudomonas aeruginosa | 27853 | purchased from US Research Nanomaterials, Inc. | Ciprofloxacin | null | null | 15 | 25 | 20 | spherical | MIC | 0.25 | null | 16 | null | null | null | null | 1.9 | null | null | null | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9495250/ | 10.3390/antibiotics11091219 | 4 | 18 | null | null | null | null | null | Antibiotics | MDPI AG | 2,022 | Silver Nanoparticle-Based Combinations with Antimicrobial Agents against Antimicrobial-Resistant Clinical Isolates | true | true | gold | 4_antibiotics-11-01219-v2.pdf | 1 |
167 | Ag | Acinetobacter baumannii | BAA-747 | purchased from US Research Nanomaterials, Inc. | Ciprofloxacin | null | null | 15 | 25 | 20 | spherical | MIC | 0.25 | null | 32 | null | null | null | null | 1.9 | null | null | null | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9495250/ | 10.3390/antibiotics11091219 | 4 | 18 | null | null | null | null | null | Antibiotics | MDPI AG | 2,022 | Silver Nanoparticle-Based Combinations with Antimicrobial Agents against Antimicrobial-Resistant Clinical Isolates | true | true | gold | 4_antibiotics-11-01219-v2.pdf | 1 |
168 | Ag | Staphylococcus aureus | 29213 | purchased from US Research Nanomaterials, Inc. | Ciprofloxacin | null | null | 15 | 25 | 20 | spherical | MIC | 0.25 | null | 256 | null | null | null | null | 1.9 | null | null | null | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9495250/ | 10.3390/antibiotics11091219 | 4 | 18 | null | null | null | null | null | Antibiotics | MDPI AG | 2,022 | Silver Nanoparticle-Based Combinations with Antimicrobial Agents against Antimicrobial-Resistant Clinical Isolates | true | true | gold | 4_antibiotics-11-01219-v2.pdf | 1 |
169 | Ag | Staphylococcus saprophyticus | 49453 | purchased from US Research Nanomaterials, Inc. | Ciprofloxacin | null | null | 15 | 25 | 20 | spherical | MIC | 0.25 | null | 256 | null | null | null | null | 1.9 | null | null | null | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9495250/ | 10.3390/antibiotics11091219 | 4 | 18 | null | null | null | null | null | Antibiotics | MDPI AG | 2,022 | Silver Nanoparticle-Based Combinations with Antimicrobial Agents against Antimicrobial-Resistant Clinical Isolates | true | true | gold | 4_antibiotics-11-01219-v2.pdf | 1 |
170 | Ag | Staphylococcus sciuri | 29061 | purchased from US Research Nanomaterials, Inc. | Ciprofloxacin | null | null | 15 | 25 | 20 | spherical | MIC | 0.25 | null | 256 | null | null | null | null | 1.9 | null | null | null | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9495250/ | 10.3390/antibiotics11091219 | 4 | 18 | null | null | null | null | null | Antibiotics | MDPI AG | 2,022 | Silver Nanoparticle-Based Combinations with Antimicrobial Agents against Antimicrobial-Resistant Clinical Isolates | true | true | gold | 4_antibiotics-11-01219-v2.pdf | 1 |
171 | Ag | Staphylococcus epidermidis | 12228 | purchased from US Research Nanomaterials, Inc. | Ciprofloxacin | null | null | 15 | 25 | 20 | spherical | MIC | 0.25 | null | 256 | null | null | null | null | 1.9 | null | null | null | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9495250/ | 10.3390/antibiotics11091219 | 4 | 18 | null | null | null | null | null | Antibiotics | MDPI AG | 2,022 | Silver Nanoparticle-Based Combinations with Antimicrobial Agents against Antimicrobial-Resistant Clinical Isolates | true | true | gold | 4_antibiotics-11-01219-v2.pdf | 1 |
172 | Ag | Escherichia coli | 25922 | purchased from US Research Nanomaterials, Inc. | Colistin | null | null | 15 | 25 | 20 | spherical | MIC | 2 | null | 64 | null | 16 | null | null | 1.9 | null | null | null | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9495250/ | 10.3390/antibiotics11091219 | 4 | 18 | null | null | null | null | null | Antibiotics | MDPI AG | 2,022 | Silver Nanoparticle-Based Combinations with Antimicrobial Agents against Antimicrobial-Resistant Clinical Isolates | true | true | gold | 4_antibiotics-11-01219-v2.pdf | 1 |
173 | Ag | Klebsiella pneumoniae | 13883 | purchased from US Research Nanomaterials, Inc. | Colistin | null | null | 15 | 25 | 20 | spherical | MIC | null | null | 128 | null | null | null | null | 1.9 | null | null | null | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9495250/ | 10.3390/antibiotics11091219 | 4 | 18 | null | null | null | null | null | Antibiotics | MDPI AG | 2,022 | Silver Nanoparticle-Based Combinations with Antimicrobial Agents against Antimicrobial-Resistant Clinical Isolates | true | true | gold | 4_antibiotics-11-01219-v2.pdf | 1 |
174 | Ag | Pseudomonas aeruginosa | 27853 | purchased from US Research Nanomaterials, Inc. | Colistin | null | null | 15 | 25 | 20 | spherical | MIC | 0.5 | null | 16 | null | null | null | null | 1.9 | null | null | null | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9495250/ | 10.3390/antibiotics11091219 | 4 | 18 | null | null | null | null | null | Antibiotics | MDPI AG | 2,022 | Silver Nanoparticle-Based Combinations with Antimicrobial Agents against Antimicrobial-Resistant Clinical Isolates | true | true | gold | 4_antibiotics-11-01219-v2.pdf | 1 |
175 | Ag | Acinetobacter baumannii | BAA-747 | purchased from US Research Nanomaterials, Inc. | Colistin | null | null | 15 | 25 | 20 | spherical | MIC | 1 | null | 32 | null | null | null | null | 1.9 | null | null | null | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9495250/ | 10.3390/antibiotics11091219 | 4 | 18 | null | null | null | null | null | Antibiotics | MDPI AG | 2,022 | Silver Nanoparticle-Based Combinations with Antimicrobial Agents against Antimicrobial-Resistant Clinical Isolates | true | true | gold | 4_antibiotics-11-01219-v2.pdf | 1 |
176 | Ag | Staphylococcus aureus | 29213 | purchased from US Research Nanomaterials, Inc. | Colistin | null | null | 15 | 25 | 20 | spherical | MIC | 256 | null | 256 | null | null | null | null | 1.9 | null | null | null | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9495250/ | 10.3390/antibiotics11091219 | 4 | 18 | null | null | null | null | null | Antibiotics | MDPI AG | 2,022 | Silver Nanoparticle-Based Combinations with Antimicrobial Agents against Antimicrobial-Resistant Clinical Isolates | true | true | gold | 4_antibiotics-11-01219-v2.pdf | 1 |
177 | Ag | Staphylococcus saprophyticus | 49453 | purchased from US Research Nanomaterials, Inc. | Colistin | null | null | 15 | 25 | 20 | spherical | MIC | 64 | null | 256 | null | null | null | null | 1.9 | null | null | null | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9495250/ | 10.3390/antibiotics11091219 | 4 | 18 | null | null | null | null | null | Antibiotics | MDPI AG | 2,022 | Silver Nanoparticle-Based Combinations with Antimicrobial Agents against Antimicrobial-Resistant Clinical Isolates | true | true | gold | 4_antibiotics-11-01219-v2.pdf | 1 |
178 | Ag | Staphylococcus sciuri | 29061 | purchased from US Research Nanomaterials, Inc. | Colistin | null | null | 15 | 25 | 20 | spherical | MIC | null | null | 256 | null | null | null | null | 1.9 | null | null | null | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9495250/ | 10.3390/antibiotics11091219 | 4 | 18 | null | null | null | null | null | Antibiotics | MDPI AG | 2,022 | Silver Nanoparticle-Based Combinations with Antimicrobial Agents against Antimicrobial-Resistant Clinical Isolates | true | true | gold | 4_antibiotics-11-01219-v2.pdf | 1 |
179 | Ag | Staphylococcus epidermidis | 12228 | purchased from US Research Nanomaterials, Inc. | Colistin | null | null | 15 | 25 | 20 | spherical | MIC | 256 | null | 256 | null | null | null | null | 1.9 | null | null | null | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9495250/ | 10.3390/antibiotics11091219 | 4 | 18 | null | null | null | null | null | Antibiotics | MDPI AG | 2,022 | Silver Nanoparticle-Based Combinations with Antimicrobial Agents against Antimicrobial-Resistant Clinical Isolates | true | true | gold | 4_antibiotics-11-01219-v2.pdf | 1 |
180 | Ag | Escherichia coli | 25922 | purchased from US Research Nanomaterials, Inc. | Rifampicin | null | null | 15 | 25 | 20 | spherical | MIC | 4 | null | 64 | null | 32 | null | null | 1.9 | null | null | null | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9495250/ | 10.3390/antibiotics11091219 | 4 | 18 | null | null | null | null | null | Antibiotics | MDPI AG | 2,022 | Silver Nanoparticle-Based Combinations with Antimicrobial Agents against Antimicrobial-Resistant Clinical Isolates | true | true | gold | 4_antibiotics-11-01219-v2.pdf | 1 |
181 | Ag | Klebsiella pneumoniae | 13883 | purchased from US Research Nanomaterials, Inc. | Rifampicin | null | null | 15 | 25 | 20 | spherical | MIC | 16 | null | 128 | null | null | null | null | 1.9 | null | null | null | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9495250/ | 10.3390/antibiotics11091219 | 4 | 18 | null | null | null | null | null | Antibiotics | MDPI AG | 2,022 | Silver Nanoparticle-Based Combinations with Antimicrobial Agents against Antimicrobial-Resistant Clinical Isolates | true | true | gold | 4_antibiotics-11-01219-v2.pdf | 1 |
182 | Ag | Pseudomonas aeruginosa | 27853 | purchased from US Research Nanomaterials, Inc. | Rifampicin | null | null | 15 | 25 | 20 | spherical | MIC | 26 | null | 16 | null | null | null | null | 1.9 | null | null | null | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9495250/ | 10.3390/antibiotics11091219 | 4 | 18 | null | null | null | null | null | Antibiotics | MDPI AG | 2,022 | Silver Nanoparticle-Based Combinations with Antimicrobial Agents against Antimicrobial-Resistant Clinical Isolates | true | true | gold | 4_antibiotics-11-01219-v2.pdf | 1 |
183 | Ag | Acinetobacter baumannii | BAA-747 | purchased from US Research Nanomaterials, Inc. | Rifampicin | null | null | 15 | 25 | 20 | spherical | MIC | 0.5 | null | 32 | null | null | null | null | 1.9 | null | null | null | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9495250/ | 10.3390/antibiotics11091219 | 4 | 18 | null | null | null | null | null | Antibiotics | MDPI AG | 2,022 | Silver Nanoparticle-Based Combinations with Antimicrobial Agents against Antimicrobial-Resistant Clinical Isolates | true | true | gold | 4_antibiotics-11-01219-v2.pdf | 1 |
184 | Ag | Staphylococcus aureus | 29213 | purchased from US Research Nanomaterials, Inc. | Rifampicin | null | null | 15 | 25 | 20 | spherical | MIC | 0.25 | null | 256 | null | null | null | null | 1.9 | null | null | null | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9495250/ | 10.3390/antibiotics11091219 | 4 | 18 | null | null | null | null | null | Antibiotics | MDPI AG | 2,022 | Silver Nanoparticle-Based Combinations with Antimicrobial Agents against Antimicrobial-Resistant Clinical Isolates | true | true | gold | 4_antibiotics-11-01219-v2.pdf | 1 |
185 | Ag | Staphylococcus saprophyticus | 49453 | purchased from US Research Nanomaterials, Inc. | Rifampicin | null | null | 15 | 25 | 20 | spherical | MIC | 0.25 | null | 256 | null | null | null | null | 1.9 | null | null | null | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9495250/ | 10.3390/antibiotics11091219 | 4 | 18 | null | null | null | null | null | Antibiotics | MDPI AG | 2,022 | Silver Nanoparticle-Based Combinations with Antimicrobial Agents against Antimicrobial-Resistant Clinical Isolates | true | true | gold | 4_antibiotics-11-01219-v2.pdf | 1 |
186 | Ag | Staphylococcus sciuri | 29061 | purchased from US Research Nanomaterials, Inc. | Rifampicin | null | null | 15 | 25 | 20 | spherical | MIC | 0.25 | null | 256 | null | null | null | null | 1.9 | null | null | null | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9495250/ | 10.3390/antibiotics11091219 | 4 | 18 | null | null | null | null | null | Antibiotics | MDPI AG | 2,022 | Silver Nanoparticle-Based Combinations with Antimicrobial Agents against Antimicrobial-Resistant Clinical Isolates | true | true | gold | 4_antibiotics-11-01219-v2.pdf | 1 |
187 | Ag | Staphylococcus epidermidis | 12228 | purchased from US Research Nanomaterials, Inc. | Rifampicin | null | null | 15 | 25 | 20 | spherical | MIC | 0.25 | null | 256 | null | null | null | null | 1.9 | null | null | null | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9495250/ | 10.3390/antibiotics11091219 | 4 | 18 | null | null | null | null | null | Antibiotics | MDPI AG | 2,022 | Silver Nanoparticle-Based Combinations with Antimicrobial Agents against Antimicrobial-Resistant Clinical Isolates | true | true | gold | 4_antibiotics-11-01219-v2.pdf | 1 |
188 | Ag | Pseudomonas aeruginosa | PAO1 | purchased from Sigma Aldrich ( citrate capped AgNPs) | Aztreonam | null | null | 10 | 10 | 10 | null | MIC | null | null | 0.234 | null | null | null | null | null | null | null | null | https://journals.asm.org/doi/10.1128/aac.03170-14#ref-list-1 | 10.1128/aac.03170-14 | 5 | 20 | null | null | null | null | null | Antimicrobial Agents and Chemotherapy | American Society for Microbiology | 2,014 | Synergy of Silver Nanoparticles and Aztreonam against Pseudomonas aeruginosa PAO1 Biofilms | false | true | bronze | 5_habash2014.pdf | 1 |
189 | Ag | Pseudomonas aeruginosa | PAO1 | purchased from Sigma Aldrich ( citrate capped AgNPs) | Aztreonam | null | null | 20 | 20 | 20 | null | MIC | null | null | 0.625 | null | null | null | null | null | null | null | null | https://journals.asm.org/doi/10.1128/aac.03170-14#ref-list-1 | 10.1128/aac.03170-14 | 5 | 20 | null | null | null | null | null | Antimicrobial Agents and Chemotherapy | American Society for Microbiology | 2,014 | Synergy of Silver Nanoparticles and Aztreonam against Pseudomonas aeruginosa PAO1 Biofilms | false | true | bronze | 5_habash2014.pdf | 1 |
190 | Ag | Pseudomonas aeruginosa | PAO1 | purchased from Sigma Aldrich ( citrate capped AgNPs) | Aztreonam | null | null | 40 | 40 | 40 | null | MIC | null | null | 1.25 | null | null | null | null | null | null | null | null | https://journals.asm.org/doi/10.1128/aac.03170-14#ref-list-1 | 10.1128/aac.03170-14 | 5 | 20 | null | null | null | null | null | Antimicrobial Agents and Chemotherapy | American Society for Microbiology | 2,014 | Synergy of Silver Nanoparticles and Aztreonam against Pseudomonas aeruginosa PAO1 Biofilms | false | true | bronze | 5_habash2014.pdf | 1 |
191 | Ag | Pseudomonas aeruginosa | PAO1 | purchased from Sigma Aldrich ( citrate capped AgNPs) | Aztreonam | null | null | 60 | 60 | 60 | null | MIC | null | null | 2.5 | null | null | null | null | null | null | null | null | https://journals.asm.org/doi/10.1128/aac.03170-14#ref-list-1 | 10.1128/aac.03170-14 | 5 | 20 | null | null | null | null | null | Antimicrobial Agents and Chemotherapy | American Society for Microbiology | 2,014 | Synergy of Silver Nanoparticles and Aztreonam against Pseudomonas aeruginosa PAO1 Biofilms | false | true | bronze | 5_habash2014.pdf | 1 |
192 | Ag | Pseudomonas aeruginosa | PAO1 | purchased from Sigma Aldrich ( citrate capped AgNPs) | Aztreonam | null | null | 100 | 100 | 100 | null | MIC | null | null | 7.5 | null | null | null | null | null | null | null | null | https://journals.asm.org/doi/10.1128/aac.03170-14#ref-list-1 | 10.1128/aac.03170-14 | 5 | 20 | null | null | null | null | null | Antimicrobial Agents and Chemotherapy | American Society for Microbiology | 2,014 | Synergy of Silver Nanoparticles and Aztreonam against Pseudomonas aeruginosa PAO1 Biofilms | false | true | bronze | 5_habash2014.pdf | 1 |
193 | Ag | Pseudomonas aeruginosa | PAO1 | purchased from Sigma Aldrich ( citrate capped AgNPs) | Aztreonam | null | null | 10 | 10 | 10 | null | MBEC | null | null | 3.75 | null | null | null | null | null | null | null | null | https://journals.asm.org/doi/10.1128/aac.03170-14#ref-list-1 | 10.1128/aac.03170-14 | 5 | 20 | null | null | null | null | null | Antimicrobial Agents and Chemotherapy | American Society for Microbiology | 2,014 | Synergy of Silver Nanoparticles and Aztreonam against Pseudomonas aeruginosa PAO1 Biofilms | false | true | bronze | 5_habash2014.pdf | 1 |
194 | Ag | Pseudomonas aeruginosa | PAO1 | purchased from Sigma Aldrich ( citrate capped AgNPs) | Aztreonam | null | null | 20 | 20 | 20 | null | MBEC | null | null | 2.5 | null | null | null | null | null | null | null | null | https://journals.asm.org/doi/10.1128/aac.03170-14#ref-list-1 | 10.1128/aac.03170-14 | 5 | 20 | null | null | null | null | null | Antimicrobial Agents and Chemotherapy | American Society for Microbiology | 2,014 | Synergy of Silver Nanoparticles and Aztreonam against Pseudomonas aeruginosa PAO1 Biofilms | false | true | bronze | 5_habash2014.pdf | 1 |
195 | Ag | Pseudomonas aeruginosa | PAO1 | purchased from Sigma Aldrich ( citrate capped AgNPs) | Aztreonam | null | null | 40 | 40 | 40 | null | MBEC | null | null | 5 | null | null | null | null | null | null | null | null | https://journals.asm.org/doi/10.1128/aac.03170-14#ref-list-1 | 10.1128/aac.03170-14 | 5 | 20 | null | null | null | null | null | Antimicrobial Agents and Chemotherapy | American Society for Microbiology | 2,014 | Synergy of Silver Nanoparticles and Aztreonam against Pseudomonas aeruginosa PAO1 Biofilms | false | true | bronze | 5_habash2014.pdf | 1 |
196 | Ag | Pseudomonas aeruginosa | PAO1 | purchased from Sigma Aldrich ( citrate capped AgNPs) | Aztreonam | null | null | 60 | 60 | 60 | null | MBEC | null | null | 10 | null | null | null | null | null | null | null | null | https://journals.asm.org/doi/10.1128/aac.03170-14#ref-list-1 | 10.1128/aac.03170-14 | 5 | 20 | null | null | null | null | null | Antimicrobial Agents and Chemotherapy | American Society for Microbiology | 2,014 | Synergy of Silver Nanoparticles and Aztreonam against Pseudomonas aeruginosa PAO1 Biofilms | false | true | bronze | 5_habash2014.pdf | 1 |
197 | Ag | Pseudomonas aeruginosa | PAO1 | purchased from Sigma Aldrich ( citrate capped AgNPs) | Aztreonam | null | null | 100 | 100 | 100 | null | MBEC | null | null | 4,000 | null | null | null | null | null | null | null | null | https://journals.asm.org/doi/10.1128/aac.03170-14#ref-list-1 | 10.1128/aac.03170-14 | 5 | 20 | null | null | null | null | null | Antimicrobial Agents and Chemotherapy | American Society for Microbiology | 2,014 | Synergy of Silver Nanoparticles and Aztreonam against Pseudomonas aeruginosa PAO1 Biofilms | false | true | bronze | 5_habash2014.pdf | 1 |
198 | Ag | Staphylococcus epidermidis | 73 | green_synthesis by Bacillus sp. | Fusidic acid | 30 | 10 | 14 | 42 | 28 | spherical | disc_diffusion | 25 | null | 15 | null | 25 | null | 0 | null | null | null | null | https://link.springer.com/article/10.1007/s12010-014-0852-z | 10.1007/s12010-014-0852-z | 6 | 24 | null | null | null | null | null | Applied Biochemistry and Biotechnology | Springer Science and Business Media LLC | 2,014 | Antibacterial Activity and Synergistic Effect of Biosynthesized AgNPs with Antibiotics Against Multidrug-Resistant Biofilm-Forming Coagulase-Negative Staphylococci Isolated from Clinical Samples | false | false | closed | 6_thomas2014.pdf | 0 |
199 | Ag | Staphylococcus epidermidis | 73 | green_synthesis by Bacillus sp. | Gentamicin | 10 | 10 | 14 | 42 | 28 | spherical | disc_diffusion | 14 | null | 15 | null | 15 | null | 0.15 | null | null | null | null | https://link.springer.com/article/10.1007/s12010-014-0852-z | 10.1007/s12010-014-0852-z | 6 | 24 | null | null | null | null | null | Applied Biochemistry and Biotechnology | Springer Science and Business Media LLC | 2,014 | Antibacterial Activity and Synergistic Effect of Biosynthesized AgNPs with Antibiotics Against Multidrug-Resistant Biofilm-Forming Coagulase-Negative Staphylococci Isolated from Clinical Samples | false | false | closed | 6_thomas2014.pdf | 0 |
200 | Ag | Staphylococcus epidermidis | 145 | green_synthesis by Bacillus sp. | Gentamicin | 10 | 10 | 14 | 42 | 28 | spherical | disc_diffusion | 7 | null | 19 | null | 10 | null | 44,652 | null | null | null | null | https://link.springer.com/article/10.1007/s12010-014-0852-z | 10.1007/s12010-014-0852-z | 6 | 24 | null | null | null | null | null | Applied Biochemistry and Biotechnology | Springer Science and Business Media LLC | 2,014 | Antibacterial Activity and Synergistic Effect of Biosynthesized AgNPs with Antibiotics Against Multidrug-Resistant Biofilm-Forming Coagulase-Negative Staphylococci Isolated from Clinical Samples | false | false | closed | 6_thomas2014.pdf | 0 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.